Unicycive Therapeutics doubles authorized common stock to 400M shares

Unicycive Therapeutics, Inc.

Stockholders approved increase from 200M to 400M shares on June 20, 2024.
Certificate of Amendment filed with Delaware on June 21, 2024, effective immediately.
No specific use of the additional shares or dilution impact disclosed.

item 5.03 item 9.01

Unicycive Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-056224

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.